In the last trading session, 5.3 million shares of the GlucoTrack Inc (NASDAQ:GCTK) were traded, and its beta was -0.16. Most recently the company’s share price was $0.27, and it changed around -$0.03 or -9.55% from the last close, which brings the market valuation of the company to $2.81M. GCTK currently trades at a discount to its 52-week high of $99.00, offering almost -36566.67% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 18.52% since then. We note from GlucoTrack Inc’s average daily trading volume that its 10-day average is 14.37 million shares, with the 3-month average coming to 6.07 million.

GlucoTrack Inc (NASDAQ:GCTK) trade information

Instantly GCTK has showed a red trend with a performance of -9.55% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5085 on recent trading dayincreased the stock’s daily price by 46.9%. The company’s shares are currently down -96.38% year-to-date, but still down -27.42% over the last five days. On the other hand, GlucoTrack Inc (NASDAQ:GCTK) is -27.79% down in the 30-day period. We can see from the shorts that 0.79 million shares have been sold at a short interest cover period of 0.2 day(s).

GlucoTrack Inc (NASDAQ:GCTK)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.34% of GlucoTrack Inc shares, and 0.43% of them are in the hands of institutional investors. The stock currently has a share float of 0.45%.

Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.08 shares worth $291.0, making up 0.01% of all outstanding shares. On the other hand, Fidelity Series Total Market Index Fund held roughly 243.0 shares worth around $65.0, which represents about 0.00% of the total shares outstanding.